Search research articles
Contact Us
Filters
Showing results (261-270 of 350) with videos related to
Page
of 35
Sort By:
Therapeutic Advances in Gastroenterology
|
August 25, 2017
Commutability and concordance of four hepatitis B virus DNA assays in an international multicenter study
Benjamin Maasoumy, Birgit Bremer, Patrick Lehmann, et al.
Plos One
|
August 21, 2012
Hepatitis B surface antigen concentrations in patients with HIV/HBV co-infection
Jerzy Jaroszewicz, Thomas Reiberger, Dirk Meyer-Olson, et al.
The Journal of Infectious Diseases
|
June 13, 2018
Contrasting Timing of Virological Relapse After Discontinuation of Tenofovir or Entecavir in Hepatitis B e Antigen-Negative Patients
Christoph Höner Zu Siederdissen, Aric Josun Hui, Wattana Sukeepaisarnjaroen, et al.
Scientific Reports
|
November 23, 2024
Different dynamics of soluble inflammatory mediators after clearance of respiratory SARS-CoV-2 versus blood-borne hepatitis C virus infections
Antonia Zeuzem, Saumya Dileep Kumar, Carlos Oltmanns, et al.
The Journal of Infectious Diseases
|
September 10, 2016
Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B
Christoph Höner Zu Siederdissen, Franziska Rinker, Benjamin Maasoumy, et al.
Nature Immunology
|
August 28, 2024
Attenuated effector T cells are linked to control of chronic HBV infection
Kathrin Heim, Sagar, Özlem Sogukpinar, et al.
Zeitschrift Fur Gastroenterologie
|
January 15, 2019
[4 years of direct-acting antivirals (DAAs) in the German Hepatitis C-Registry (DHC-R)]
Dietrich Hüppe, Yvonne Serfert, Peter Buggisch, et al.
Plos One
|
April 11, 2020
Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B
Patrick Marcellin, Qing Xie, Seung Woon Paik, et al.
The Journal of Infectious Diseases
|
October 25, 2013
Compromised function of natural killer cells in acute and chronic viral hepatitis
Sebastian Lunemann, David F G Malone, Julia Hengst, et al.
Hepatology (Baltimore, Md.)
|
March 4, 2014
Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta
Benjamin Heidrich, Cihan Yurdaydın, Gökhan Kabaçam, et al.
Page
of 35
Search research articles
Search
Showing results (261-270 of 350) with videos related to
Sort By:
Page
of 35
Therapeutic Advances in Gastroenterology
|
August 25, 2017
Commutability and concordance of four hepatitis B virus DNA assays in an international multicenter study
Benjamin Maasoumy, Birgit Bremer, Patrick Lehmann, et al.
Plos One
|
August 21, 2012
Hepatitis B surface antigen concentrations in patients with HIV/HBV co-infection
Jerzy Jaroszewicz, Thomas Reiberger, Dirk Meyer-Olson, et al.
The Journal of Infectious Diseases
|
June 13, 2018
Contrasting Timing of Virological Relapse After Discontinuation of Tenofovir or Entecavir in Hepatitis B e Antigen-Negative Patients
Christoph Höner Zu Siederdissen, Aric Josun Hui, Wattana Sukeepaisarnjaroen, et al.
Scientific Reports
|
November 23, 2024
Different dynamics of soluble inflammatory mediators after clearance of respiratory SARS-CoV-2 versus blood-borne hepatitis C virus infections
Antonia Zeuzem, Saumya Dileep Kumar, Carlos Oltmanns, et al.
The Journal of Infectious Diseases
|
September 10, 2016
Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B
Christoph Höner Zu Siederdissen, Franziska Rinker, Benjamin Maasoumy, et al.
Nature Immunology
|
August 28, 2024
Attenuated effector T cells are linked to control of chronic HBV infection
Kathrin Heim, Sagar, Özlem Sogukpinar, et al.
Zeitschrift Fur Gastroenterologie
|
January 15, 2019
[4 years of direct-acting antivirals (DAAs) in the German Hepatitis C-Registry (DHC-R)]
Dietrich Hüppe, Yvonne Serfert, Peter Buggisch, et al.
Plos One
|
April 11, 2020
Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B
Patrick Marcellin, Qing Xie, Seung Woon Paik, et al.
The Journal of Infectious Diseases
|
October 25, 2013
Compromised function of natural killer cells in acute and chronic viral hepatitis
Sebastian Lunemann, David F G Malone, Julia Hengst, et al.
Hepatology (Baltimore, Md.)
|
March 4, 2014
Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta
Benjamin Heidrich, Cihan Yurdaydın, Gökhan Kabaçam, et al.
Page
of 35